The importance of endotoxin contamination control in parenteral manufacturing becomes apparent when confronted with four aspects of its existence. The first is its ubiquity in nature, the second is the potent toxicity it displays relative to other pyrogens, the third is its stability . . . and the fourth is the relative likelihood of its occurrence in parenteral solutions.